The authors wish to point out that there is a spelling error in one of the labels in Fig. 3 and Fig. S3. In both Figures, panel A, “E-Catenin” should read “E-Cadherin”.
. 2019 May 14;43:650. doi: 10.1016/j.ebiom.2019.05.001
Corrigendum to “A PLK1 kinase inhibitor enhances the chemosensitivity of cisplatin by inducing pyroptosis in oesophageal squamous cell carcinoma” [EBioMedicine 41 (2019) 244–255]
Mengjiao Wu
a, Yan Wang
a, Di Yang
a, Ying Gong
a, Feng Rao
b, Rui Liu
a, Yeerken Danna
a, Jinting Li
a, Jiawen Fan
a, Jie Chen
a, Weimin Zhang
a,⁎, Qimin Zhan
a,⁎
Mengjiao Wu
aKey laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Laboratory of Molecular Oncology, Peking University Cancer Hospital & Institute, Beijing 100142, China
Find articles by Mengjiao Wu
Yan Wang
aKey laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Laboratory of Molecular Oncology, Peking University Cancer Hospital & Institute, Beijing 100142, China
Find articles by Yan Wang
Di Yang
aKey laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Laboratory of Molecular Oncology, Peking University Cancer Hospital & Institute, Beijing 100142, China
Find articles by Di Yang
Ying Gong
aKey laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Laboratory of Molecular Oncology, Peking University Cancer Hospital & Institute, Beijing 100142, China
Find articles by Ying Gong
Feng Rao
bDepartment of Orthopedics and Trauma, Peking University People's Hospital, Beijing, China
Find articles by Feng Rao
Rui Liu
aKey laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Laboratory of Molecular Oncology, Peking University Cancer Hospital & Institute, Beijing 100142, China
Find articles by Rui Liu
Yeerken Danna
aKey laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Laboratory of Molecular Oncology, Peking University Cancer Hospital & Institute, Beijing 100142, China
Find articles by Yeerken Danna
Jinting Li
aKey laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Laboratory of Molecular Oncology, Peking University Cancer Hospital & Institute, Beijing 100142, China
Find articles by Jinting Li
Jiawen Fan
aKey laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Laboratory of Molecular Oncology, Peking University Cancer Hospital & Institute, Beijing 100142, China
Find articles by Jiawen Fan
Jie Chen
aKey laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Laboratory of Molecular Oncology, Peking University Cancer Hospital & Institute, Beijing 100142, China
Find articles by Jie Chen
Weimin Zhang
aKey laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Laboratory of Molecular Oncology, Peking University Cancer Hospital & Institute, Beijing 100142, China
Find articles by Weimin Zhang
Qimin Zhan
aKey laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Laboratory of Molecular Oncology, Peking University Cancer Hospital & Institute, Beijing 100142, China
Find articles by Qimin Zhan
aKey laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Laboratory of Molecular Oncology, Peking University Cancer Hospital & Institute, Beijing 100142, China
bDepartment of Orthopedics and Trauma, Peking University People's Hospital, Beijing, China
⁎
Corresponding authors. qiminzhan@vip.163.com
Collection date 2019 May.
© 2019 The Authors
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
PMCID: PMC6558293 PMID: 31097408
This corrects the article "A PLK1 kinase inhibitor enhances the chemosensitivity of cisplatin by inducing pyroptosis in oesophageal squamous cell carcinoma" in volume 41 on page 244.